In most patients with PAD, both systemic IgG and local IgA are absent or dysfunctional; indeed, one of the criteria in the definition of CVID in the revised ESID and International Consensus guidelines is low IgA and/or low IgM (22, 23). This evidence concerns the gene CD79A and peripheral arterial disease.